Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data
Background: To construct an effective prognostic index to predict overall survival (OS) and triplet regimen efficacy for advanced gastric cancer (AGC) patients treated with platinum-based and fluorouracil-based chemotherapy. Objectives: Between 2011 and 2021, 679 patients from two randomized phase I...
Main Authors: | Wan-Jing Feng, Xiao-Ying Zhao, Yi-Fu He, Ming-Zhu Huang, Zhi-Yu Chen, Yu-Sheng Wang, Xiao-Dong Zhu, Wei-Jian Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-02-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359241233982 |
Similar Items
-
XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)
by: Xiao‐Dong Zhu, et al.
Published: (2022-04-01) -
The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
by: Yuting Pan, et al.
Published: (2023-10-01) -
The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer
by: Ahmet Ozveren, et al.
Published: (2023-05-01) -
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients
by: Jieping Qiu, et al.
Published: (2020-05-01) -
Prognostic value of Geriatric Nutritional Risk Index and systemic immune-inflammatory index in elderly patients with acute coronary syndromes
by: Xing-Yu Zhu, et al.
Published: (2024-02-01)